Beta Labs LTD is recalling the dietary supplements Oxyphen XR, Phentalene, Phen FX, and Red Vipers Lot because they contain the potentially dangerous ingredient 1,3 dimethylamylamine (“DMAA”). The Products contain DMAA. Ingesting DMAA can elevate blood pressure and lead to cardiovascular problems. Consumers who have purchased these products should not use them.
The UPC codes and lot numbers for the recalled products are as follows: Oxyphen XR, UPC 70541 59974, Lot #s 200910 and 200911; Phentalene UPC 70541 59982, Lot # 58800512; Phen FX UPC 29882 55980, Lot # 1205129; and Red Vipers UPC 29882 55981, Lot # 1205128. The products were all sold in capsule form. The recalled products were sold nationwide.
The U.S. Food and Drug Administration (FDA) has warned consumers that DMAA is potentially dangerous to health. It can elevate blood pressure and could cause heart attack, shortness of breath, tightening of the chest and other cardiovascular problems. The FDA has received 86 reports of illnesses and death associated with supplements containing DMAA as of April 11, 2013, according to the agency.
At this point, there have been no reports of adverse events associated with the products under recall. No other products distributed by Beta are included in the recall.
Consumers with questions can contact Beta at [email protected] or by calling 1- 877-283-1742, Monday – Friday, 10 a.m. – 5 p.m. CST. Adverse reactions or quality problems experienced in association with the use of these product(s) may be reported to the FDA’s MedWatch Adverse Event Reporting program online, by regular mail, or by fax. The form and instructions for the form may be found at http://www.fda.gov/Medwatch/getforms.htm
